State Street Health Care Select Sector SPDR ETF XLV
188.95 USD +0.07 (+0.04%)
At closeNov 12, 2026, 4:10 AM EST
190.64 +1.69 +0.89%
Pre-market · Nov 12, 4:10 AM ET
186.85 Day range 189.28
141.97 52-week range 192.32
- YTD
- +22.06%
- 1 year
- +25.40%
- Market cap
- 50.79B
- EPS (ttm)
- 6.13
- P/E ratio
- 30.80
- YTD return
- +22.06%
- 1-year return
- +25.40%
- Volume
- 8.25M
- Avg volume
- 9.03M
- Open
- 187.39
- Previous close
- 188.88
- Day's range
- 186.85 – 189.28
- 52-week range
- 141.97 – 192.32
- Earnings date
- May 15, 2006
5D -1.80 (-0.94%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 174.09
- 200-day average
- 159.69
Next earnings
May 15, 2006
Expected May 15, 2006. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 15, 2006 | Dec 31, 2005 | 0.46 | — | — | — |
| Feb 15, 2005 | Sep 30, 2004 | 0.40 | 0.41 | +0.01 | +2.50% |
About State Street Health Care Select Sector SPDR ETF
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
News
ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win
Nasdaq 100 Jumps 2.8% as CoreWeave, Nvidia Climb: Stock Market Today
Cyclicals Lead Sectors In Wednesday Trading As Defensives Trail
NVIDIA Governance Woes: 3 Areas to Buy From Amid AI Market Slump
11 Of 11 Sectors Fall In Tuesday Trading As Leaders Move Together
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
11 Of 11 Sectors Rise Monday As Growth Leads
U.S. Job Growth Beats Expectations in October: Sector ETFs in Focus
Why the prognosis for healthcare stocks is uncertain ahead of Congress' new makeup
Growth Lead Sectors In Friday Trading As Defensives Trail
Your note
Sign in to keep a note on XLV — it syncs with the Stock Master app.
